Suppr超能文献

临床实践中帕金森病深部脑刺激的基础:第1部分。

Fundamentals of deep brain stimulation for Parkinson's disease in clinical practice: part 1.

作者信息

Aquino Camila Henriques de, Moscovich Mariana, Marinho Murilo Martinez, Barcelos Lorena Broseghini, Felício André C, Halverson Matthew, Hamani Clement, Ferraz Henrique Ballalai, Munhoz Renato Puppi

机构信息

University of Calgary, Cumming School of Medicine, Department of Clinical Neurosciences, Calgary, AB, Canada.

University of Calgary, Hotchkiss Brain Institute, Calgary, AB, Canada.

出版信息

Arq Neuropsiquiatr. 2024 Apr;82(4):1-9. doi: 10.1055/s-0044-1786026. Epub 2024 Apr 23.

Abstract

Deep brain stimulation (DBS) is recognized as an established therapy for Parkinson's disease (PD) and other movement disorders in the light of the developments seen over the past three decades. Long-term efficacy is established for PD with documented improvement in the cardinal motor symptoms of PD and levodopa-induced complications, such as motor fluctuations and dyskinesias. Timing of patient selection is crucial to obtain optimal benefits from DBS therapy, before PD complications become irreversible. The objective of this first part review is to examine the fundamental concepts of DBS for PD in clinical practice, discussing the historical aspects, patient selection, potential effects of DBS on motor and non-motor symptoms, and the practical management of patients after surgery.

摘要

鉴于过去三十年所取得的进展,深部脑刺激术(DBS)被公认为是治疗帕金森病(PD)和其他运动障碍的一种成熟疗法。对于帕金森病,其长期疗效已得到确立,有记录表明,帕金森病的主要运动症状以及左旋多巴引起的并发症(如运动波动和异动症)均有改善。在帕金森病并发症变得不可逆转之前,选择合适的患者时机对于从DBS治疗中获得最佳疗效至关重要。本综述第一部分的目的是探讨临床实践中用于帕金森病的DBS的基本概念,讨论其历史背景、患者选择、DBS对运动和非运动症状的潜在影响以及术后患者的实际管理。

相似文献

1
Fundamentals of deep brain stimulation for Parkinson's disease in clinical practice: part 1.
Arq Neuropsiquiatr. 2024 Apr;82(4):1-9. doi: 10.1055/s-0044-1786026. Epub 2024 Apr 23.
4
Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
Expert Rev Neurother. 2015 Oct;15(10):1151-60. doi: 10.1586/14737175.2015.1081815. Epub 2015 Sep 17.
5
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum.
Parkinsonism Relat Disord. 2021 May;86:5-9. doi: 10.1016/j.parkreldis.2021.03.017. Epub 2021 Mar 28.
7
Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
Neuroimage Clin. 2018 May 9;19:1025-1035. doi: 10.1016/j.nicl.2018.05.006. eCollection 2018.
8
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson's disease.
J Parkinsons Dis. 2024 Nov;14(8):1614-1622. doi: 10.1177/1877718X241296014. Epub 2024 Dec 8.

本文引用的文献

1
Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia.
Brain Behav. 2021 Aug;11(8):e2292. doi: 10.1002/brb3.2292. Epub 2021 Jul 21.
2
Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease.
Mov Disord Clin Pract. 2021 Mar 11;8(3):400-405. doi: 10.1002/mdc3.13154. eCollection 2021 Apr.
3
Levodopa challenge test: indications, protocol, and guide.
J Neurol. 2021 Sep;268(9):3135-3143. doi: 10.1007/s00415-020-09810-7. Epub 2020 Apr 24.
4
What predicts quality of life after subthalamic deep brain stimulation in Parkinson's disease? A systematic review.
Eur J Neurol. 2020 Mar;27(3):419-428. doi: 10.1111/ene.14147. Epub 2020 Jan 24.
5
Decisions about deep brain stimulation therapy in Parkinson's disease.
Arq Neuropsiquiatr. 2018 Jun;76(6):411-420. doi: 10.1590/0004-282X20180048.
7
Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.
Mov Disord. 2018 Feb;33(2):208-218. doi: 10.1002/mds.27233. Epub 2017 Nov 23.
8
Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.
Mov Disord Clin Pract. 2017 Mar-Apr;4(2):183-190. doi: 10.1002/mdc3.12375. Epub 2016 Jun 6.
9
Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
Parkinsonism Relat Disord. 2017 Jun;39:37-43. doi: 10.1016/j.parkreldis.2017.02.007. Epub 2017 Feb 7.
10
Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test.
Parkinsonism Relat Disord. 2016 Jul;28:100-6. doi: 10.1016/j.parkreldis.2016.04.034. Epub 2016 Apr 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验